Research ArticleAccepted Article
Rituximab associated vasculitis flare: incidence, predictors and outcome
A.C. Desbois, L. Biard, D Sene, I. Brocheriou, P. Rouvier, B. Lioger, L. Musset, S. Candon, T. Zenone, M. Resche-Rigon, J.C. Piette, N. Benameur, P. Cacoub and D. Saadoun
The Journal of Rheumatology August 2019, jrheum.190076; DOI: https://doi.org/10.3899/jrheum.190076
A.C. Desbois
From DHU Inflammation, Immunopathologie, Biothérapie, Université Pierre et Marie Curie, Paris VI, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, F-75013, Paris, France; Département de Biostatistiques, Hôpital Saint-Louis, Paris, France; AP-HP, Groupe Hospitalier Lariboisière, Department of Internal Medicine, Paris, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Pathology, Paris, France; Hôpital Bretonneau, Centre Hospitalier de Tours, Department of Internal Medicine, Tours, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Laboratory of Immunology, Paris, France; Hôpital Necker, Laboratory of Immunology, Paris, France; Centre Hospitalier de Valence, Department of Internal Medicine, Valence, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Pharmacy, Paris, France. Address correspondence to Correspondence should be addressed to: David Saadoun, AP-HP, Hôpital Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, 83 boulevard de l’hôpital. F-75013, Paris, France. E-Mail: david.saadoun@aphp.fr
L. Biard
From DHU Inflammation, Immunopathologie, Biothérapie, Université Pierre et Marie Curie, Paris VI, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, F-75013, Paris, France; Département de Biostatistiques, Hôpital Saint-Louis, Paris, France; AP-HP, Groupe Hospitalier Lariboisière, Department of Internal Medicine, Paris, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Pathology, Paris, France; Hôpital Bretonneau, Centre Hospitalier de Tours, Department of Internal Medicine, Tours, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Laboratory of Immunology, Paris, France; Hôpital Necker, Laboratory of Immunology, Paris, France; Centre Hospitalier de Valence, Department of Internal Medicine, Valence, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Pharmacy, Paris, France. Address correspondence to Correspondence should be addressed to: David Saadoun, AP-HP, Hôpital Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, 83 boulevard de l’hôpital. F-75013, Paris, France. E-Mail: david.saadoun@aphp.fr
D Sene
From DHU Inflammation, Immunopathologie, Biothérapie, Université Pierre et Marie Curie, Paris VI, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, F-75013, Paris, France; Département de Biostatistiques, Hôpital Saint-Louis, Paris, France; AP-HP, Groupe Hospitalier Lariboisière, Department of Internal Medicine, Paris, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Pathology, Paris, France; Hôpital Bretonneau, Centre Hospitalier de Tours, Department of Internal Medicine, Tours, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Laboratory of Immunology, Paris, France; Hôpital Necker, Laboratory of Immunology, Paris, France; Centre Hospitalier de Valence, Department of Internal Medicine, Valence, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Pharmacy, Paris, France. Address correspondence to Correspondence should be addressed to: David Saadoun, AP-HP, Hôpital Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, 83 boulevard de l’hôpital. F-75013, Paris, France. E-Mail: david.saadoun@aphp.fr
I. Brocheriou
From DHU Inflammation, Immunopathologie, Biothérapie, Université Pierre et Marie Curie, Paris VI, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, F-75013, Paris, France; Département de Biostatistiques, Hôpital Saint-Louis, Paris, France; AP-HP, Groupe Hospitalier Lariboisière, Department of Internal Medicine, Paris, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Pathology, Paris, France; Hôpital Bretonneau, Centre Hospitalier de Tours, Department of Internal Medicine, Tours, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Laboratory of Immunology, Paris, France; Hôpital Necker, Laboratory of Immunology, Paris, France; Centre Hospitalier de Valence, Department of Internal Medicine, Valence, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Pharmacy, Paris, France. Address correspondence to Correspondence should be addressed to: David Saadoun, AP-HP, Hôpital Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, 83 boulevard de l’hôpital. F-75013, Paris, France. E-Mail: david.saadoun@aphp.fr
P. Rouvier
From DHU Inflammation, Immunopathologie, Biothérapie, Université Pierre et Marie Curie, Paris VI, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, F-75013, Paris, France; Département de Biostatistiques, Hôpital Saint-Louis, Paris, France; AP-HP, Groupe Hospitalier Lariboisière, Department of Internal Medicine, Paris, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Pathology, Paris, France; Hôpital Bretonneau, Centre Hospitalier de Tours, Department of Internal Medicine, Tours, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Laboratory of Immunology, Paris, France; Hôpital Necker, Laboratory of Immunology, Paris, France; Centre Hospitalier de Valence, Department of Internal Medicine, Valence, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Pharmacy, Paris, France. Address correspondence to Correspondence should be addressed to: David Saadoun, AP-HP, Hôpital Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, 83 boulevard de l’hôpital. F-75013, Paris, France. E-Mail: david.saadoun@aphp.fr
B. Lioger
From DHU Inflammation, Immunopathologie, Biothérapie, Université Pierre et Marie Curie, Paris VI, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, F-75013, Paris, France; Département de Biostatistiques, Hôpital Saint-Louis, Paris, France; AP-HP, Groupe Hospitalier Lariboisière, Department of Internal Medicine, Paris, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Pathology, Paris, France; Hôpital Bretonneau, Centre Hospitalier de Tours, Department of Internal Medicine, Tours, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Laboratory of Immunology, Paris, France; Hôpital Necker, Laboratory of Immunology, Paris, France; Centre Hospitalier de Valence, Department of Internal Medicine, Valence, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Pharmacy, Paris, France. Address correspondence to Correspondence should be addressed to: David Saadoun, AP-HP, Hôpital Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, 83 boulevard de l’hôpital. F-75013, Paris, France. E-Mail: david.saadoun@aphp.fr
L. Musset
From DHU Inflammation, Immunopathologie, Biothérapie, Université Pierre et Marie Curie, Paris VI, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, F-75013, Paris, France; Département de Biostatistiques, Hôpital Saint-Louis, Paris, France; AP-HP, Groupe Hospitalier Lariboisière, Department of Internal Medicine, Paris, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Pathology, Paris, France; Hôpital Bretonneau, Centre Hospitalier de Tours, Department of Internal Medicine, Tours, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Laboratory of Immunology, Paris, France; Hôpital Necker, Laboratory of Immunology, Paris, France; Centre Hospitalier de Valence, Department of Internal Medicine, Valence, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Pharmacy, Paris, France. Address correspondence to Correspondence should be addressed to: David Saadoun, AP-HP, Hôpital Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, 83 boulevard de l’hôpital. F-75013, Paris, France. E-Mail: david.saadoun@aphp.fr
S. Candon
From DHU Inflammation, Immunopathologie, Biothérapie, Université Pierre et Marie Curie, Paris VI, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, F-75013, Paris, France; Département de Biostatistiques, Hôpital Saint-Louis, Paris, France; AP-HP, Groupe Hospitalier Lariboisière, Department of Internal Medicine, Paris, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Pathology, Paris, France; Hôpital Bretonneau, Centre Hospitalier de Tours, Department of Internal Medicine, Tours, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Laboratory of Immunology, Paris, France; Hôpital Necker, Laboratory of Immunology, Paris, France; Centre Hospitalier de Valence, Department of Internal Medicine, Valence, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Pharmacy, Paris, France. Address correspondence to Correspondence should be addressed to: David Saadoun, AP-HP, Hôpital Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, 83 boulevard de l’hôpital. F-75013, Paris, France. E-Mail: david.saadoun@aphp.fr
T. Zenone
From DHU Inflammation, Immunopathologie, Biothérapie, Université Pierre et Marie Curie, Paris VI, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, F-75013, Paris, France; Département de Biostatistiques, Hôpital Saint-Louis, Paris, France; AP-HP, Groupe Hospitalier Lariboisière, Department of Internal Medicine, Paris, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Pathology, Paris, France; Hôpital Bretonneau, Centre Hospitalier de Tours, Department of Internal Medicine, Tours, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Laboratory of Immunology, Paris, France; Hôpital Necker, Laboratory of Immunology, Paris, France; Centre Hospitalier de Valence, Department of Internal Medicine, Valence, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Pharmacy, Paris, France. Address correspondence to Correspondence should be addressed to: David Saadoun, AP-HP, Hôpital Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, 83 boulevard de l’hôpital. F-75013, Paris, France. E-Mail: david.saadoun@aphp.fr
M. Resche-Rigon
From DHU Inflammation, Immunopathologie, Biothérapie, Université Pierre et Marie Curie, Paris VI, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, F-75013, Paris, France; Département de Biostatistiques, Hôpital Saint-Louis, Paris, France; AP-HP, Groupe Hospitalier Lariboisière, Department of Internal Medicine, Paris, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Pathology, Paris, France; Hôpital Bretonneau, Centre Hospitalier de Tours, Department of Internal Medicine, Tours, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Laboratory of Immunology, Paris, France; Hôpital Necker, Laboratory of Immunology, Paris, France; Centre Hospitalier de Valence, Department of Internal Medicine, Valence, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Pharmacy, Paris, France. Address correspondence to Correspondence should be addressed to: David Saadoun, AP-HP, Hôpital Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, 83 boulevard de l’hôpital. F-75013, Paris, France. E-Mail: david.saadoun@aphp.fr
J.C. Piette
From DHU Inflammation, Immunopathologie, Biothérapie, Université Pierre et Marie Curie, Paris VI, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, F-75013, Paris, France; Département de Biostatistiques, Hôpital Saint-Louis, Paris, France; AP-HP, Groupe Hospitalier Lariboisière, Department of Internal Medicine, Paris, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Pathology, Paris, France; Hôpital Bretonneau, Centre Hospitalier de Tours, Department of Internal Medicine, Tours, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Laboratory of Immunology, Paris, France; Hôpital Necker, Laboratory of Immunology, Paris, France; Centre Hospitalier de Valence, Department of Internal Medicine, Valence, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Pharmacy, Paris, France. Address correspondence to Correspondence should be addressed to: David Saadoun, AP-HP, Hôpital Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, 83 boulevard de l’hôpital. F-75013, Paris, France. E-Mail: david.saadoun@aphp.fr
N. Benameur
From DHU Inflammation, Immunopathologie, Biothérapie, Université Pierre et Marie Curie, Paris VI, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, F-75013, Paris, France; Département de Biostatistiques, Hôpital Saint-Louis, Paris, France; AP-HP, Groupe Hospitalier Lariboisière, Department of Internal Medicine, Paris, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Pathology, Paris, France; Hôpital Bretonneau, Centre Hospitalier de Tours, Department of Internal Medicine, Tours, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Laboratory of Immunology, Paris, France; Hôpital Necker, Laboratory of Immunology, Paris, France; Centre Hospitalier de Valence, Department of Internal Medicine, Valence, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Pharmacy, Paris, France. Address correspondence to Correspondence should be addressed to: David Saadoun, AP-HP, Hôpital Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, 83 boulevard de l’hôpital. F-75013, Paris, France. E-Mail: david.saadoun@aphp.fr
P. Cacoub
From DHU Inflammation, Immunopathologie, Biothérapie, Université Pierre et Marie Curie, Paris VI, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, F-75013, Paris, France; Département de Biostatistiques, Hôpital Saint-Louis, Paris, France; AP-HP, Groupe Hospitalier Lariboisière, Department of Internal Medicine, Paris, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Pathology, Paris, France; Hôpital Bretonneau, Centre Hospitalier de Tours, Department of Internal Medicine, Tours, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Laboratory of Immunology, Paris, France; Hôpital Necker, Laboratory of Immunology, Paris, France; Centre Hospitalier de Valence, Department of Internal Medicine, Valence, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Pharmacy, Paris, France. Address correspondence to Correspondence should be addressed to: David Saadoun, AP-HP, Hôpital Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, 83 boulevard de l’hôpital. F-75013, Paris, France. E-Mail: david.saadoun@aphp.fr
D. Saadoun
From DHU Inflammation, Immunopathologie, Biothérapie, Université Pierre et Marie Curie, Paris VI, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, F-75013, Paris, France; Département de Biostatistiques, Hôpital Saint-Louis, Paris, France; AP-HP, Groupe Hospitalier Lariboisière, Department of Internal Medicine, Paris, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Pathology, Paris, France; Hôpital Bretonneau, Centre Hospitalier de Tours, Department of Internal Medicine, Tours, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Laboratory of Immunology, Paris, France; Hôpital Necker, Laboratory of Immunology, Paris, France; Centre Hospitalier de Valence, Department of Internal Medicine, Valence, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Pharmacy, Paris, France. Address correspondence to Correspondence should be addressed to: David Saadoun, AP-HP, Hôpital Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, 83 boulevard de l’hôpital. F-75013, Paris, France. E-Mail: david.saadoun@aphp.fr
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Accepted manuscript
Rituximab associated vasculitis flare: incidence, predictors and outcome
A.C. Desbois, L. Biard, D Sene, I. Brocheriou, P. Rouvier, B. Lioger, L. Musset, S. Candon, T. Zenone, M. Resche-Rigon, J.C. Piette, N. Benameur, P. Cacoub, D. Saadoun
The Journal of Rheumatology Aug 2019, jrheum.190076; DOI: 10.3899/jrheum.190076
Accepted manuscript
Rituximab associated vasculitis flare: incidence, predictors and outcome
A.C. Desbois, L. Biard, D Sene, I. Brocheriou, P. Rouvier, B. Lioger, L. Musset, S. Candon, T. Zenone, M. Resche-Rigon, J.C. Piette, N. Benameur, P. Cacoub, D. Saadoun
The Journal of Rheumatology Aug 2019, jrheum.190076; DOI: 10.3899/jrheum.190076